Skip to content

Opaleye Management Inc., 10% owner at Grace Therapeutics, bought GRCE on Oct 1, 2026

Data as of Oct 16

▲ BUY$79K38,796 shares at $2.04Opaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.
Watch GRCE
Traded
Oct 1, 2026
Disclosed
Oct 5, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Opaleye Management Inc., 10% owner at Grace Therapeutics, bought GRCE on Oct 1, 2026TRADEDDISCLOSED
GRCESimilar stocks (XLV — its sector index fund), rebased to GRCE's price on the disclosure day
GRCE since disclosure
−8.3%
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Oct 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$3.5Kdisclosed Oct 5 · filed the same day
  2. ▲ BUYOpaleye Management Inc. 10% ownerGRCE Grace Therapeutics, Inc.$41.4Kdisclosed Oct 5 · filed 3 days after the trade

See every trade on GRCE →